Exelixis, Inc. (EXEL) Posts Q1 Loss of 39c/Share
Tweet
Share
E-mailGet Alerts EXEL Hot Sheet
Price: $50.38 --0%
Financial Fact:
Loss from operations: -25.14M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Loss from operations: -25.14M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Exelixis, Inc. (NASDAQ: EXEL) reported Q1 EPS of ($0.39), $0.02 worse than the analyst estimate of ($0.37). Revenue for the quarter came in at $4.9 million versus the consensus estimate of $6.11 million.
For earnings history and earnings-related data on Exelixis, Inc. (EXEL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
- Madison Square Garden Sports Corp. (MSGS) Tops Q4 EPS by 62c
- Intuitive Machines, Inc. (LUNR) Misses Q2 EPS by 20c, Misses on Revenue; Offers FY26 Revenue Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
